The final trades of the day with CNBC’s Melissa Lee and the Fast Money traders. Donald Trump Says Americans May 'Give Up Your Religion' if Taxes Go Up Here's What To Do If You See A Coyote In Your Yar ...

Regulus Therapeutics (RLS) contingent value right may be worth $3-$4 a share in its planned sale to Novartis ( NVS ), ...

Despite patent expirations, Novartis' strong cash flow, ongoing buyback, and low-risk profile support our continued buy ...

Q1 2025 Earnings Call Transcript April 29, 2025 Novartis AG beats earnings expectations. Reported EPS is $2.28, expectations ...

Novartis AG (NVS) reports robust sales and income growth, while navigating challenges and enhancing its product pipeline.

Novartis raises 2025 sales and profit forecast as key drugs drive strong Q1 results; core operating income up 23% to $5.6 ...

Earnings Per Share (EPS) of $2.28, beating the estimated $2.12. Revenue of approximately $13.23 billion, slightly below the ...

Although the revenue and EPS for Novartis (NVS) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street ...

NVS' first-quarter earnings and sales beat estimates. Based on the strong momentum of its key drugs, the company raises its ...

The need for NavIC was cemented after India was denied access to crucial navigation data from global providers during the ...

Novartis has done a little spring cleaning, sweeping a phase 2 osteoarthritis prospect and first-in-human radioconjugate out of its pipeline after assessing evidence on the programs. | Novartis has ...

Apply Online for 173 vacancies by May 5, 2025, at navodaya.gov.in. Check here for eligibility criteria, salary and ...